Isolation of tumor-specific cytotoxic CD4+ and CD4+CD8dim+ T-cell clones infiltrating a cutaneous T-cell lymphoma

Blood

Volumn 91, Issue 11, 1998, Pages 4331-4341

  Bagot, Martine ^a   Echchakir, Hamid ^b   Mami Chouaib, Fathia ^b   Delfau Larue, Marie Hélène ^b   Charue, Dominique ^b   Bernheim, Alain ^b   Chouaib, Salem ^b   Boumsell, Laurence ^b   Bensussan, Armand ^b  

^a INSERM   (France)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; CD8 ANTIGEN; INTERLEUKIN 2; INTERLEUKIN 7; T LYMPHOCYTE RECEPTOR;

AGED; ANTIGEN EXPRESSION; ARTICLE; CASE REPORT; CELL ISOLATION; CHROMOSOME 7; CONTROLLED STUDY; HUMAN; HUMAN CELL; MALE; PRIORITY JOURNAL; T CELL LYMPHOMA; T LYMPHOCYTE; T LYMPHOCYTE RECEPTOR GENE; TRISOMY; TUMOR ASSOCIATED LEUKOCYTE;

EID: 0032101598     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.11.4331     Document Type: Article

References (51)

1. Old LJ: Cancer immunology: the search for specificity. Cancer Res 41:361, 1981
2. Young JW, Inaba K: Dendritic cells as adjuvants for class I major histoeompatibility complex-restricted antitumor immunity. J Exp Med 183:7, 1996
3. Anichini A, Fossati G, Parmiani G: Clonal analysis of cytotoxic T-lymphocyte response to autologous human metastatic melanoma. Int J Cancer 35:683, 1985
4. Muul LM, Spiess PJ, Director EP, Rosenberg SA: Identification of specific cytolytic immune responses against autologous tumor in humans bearing malignant melanoma. J Immunol 138:989, 1987
5. Herin M, Lemoine C, Weynants P, Vessiere F, Van Pel A, Knuth A, Devos R, Boon T: Production of stable cytolytic T-cell clones directed against autologous human melanoma. Int J Cancer 39:390, 1987
6. Itoh K, Platsoucas CD, Balch CM: Autologous tumor-specific cytotoxic T lymphocytes in the infiltrate of human metastatic melanomas. Activation by interleukin 2 and autologous tumor cells, and involvement of the T cell receptor. J Exp Med 168:1419, 1988
7. Wolfel T, Klehmann E, Muller C, Schutt KH, Meyer zum Buschenfelde H, Knuth A: Lysis of human melanoma cells by autologous cytolytic T cell clones. J Exp Med 170:797, 1989
8. Topalian SL, Solomon D, Rosenberg SA: Tumor-specific cytolysis by lymphocytes infiltrating human melanomas. J Immunol 142: 3714, 1989
9. Bachelez H, Flageul B, Degos L, Boumsell L, Bensussan A: TCR gamma-delta bearing T lymphocytes infiltrating human primary cutaneous melanomas. J Invest Dermatol 98:369, 1992
10. Mackensen A, Fenradini L, Carcelain G, Triebel F, Faure F, Viel S, Hercend T: Evidence for in situ amplification of cytotoxic T-lymphocytes with antitumor activity in a human regressive melanoma. Cancer Res 53:3569, 1993
11. Van der Bruggen P, Traversari C, Chomez P, Lurquin E, De Plaen E, Van den Eynde B, Knuth A, Boon T: A gene encoding an antigen recognized by cytolytic T lymphocytes on human melanoma. Science 254:1643, 1991
12. Boël P, Wildmann C, Sensi ML, Brasseur F, Renauld JC, Coulie P, Boon T, Van der Bruggen P: BAGE, a new gene encoding an antigen recognized on human melanomas by cytolytic T lymphocytes. Immunity 2:167, 1995
13. Van den Eynde B, Peelers O, De Backer O, Gaugler B, Lucas S, Boon T: A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 182:689, 1995
14. Weynants P, Lethé B, Brasseur F, Marchand M, Boon T: Expression of MAGE genes by non-small-cell lung carcinomas. Int J Cancer 56:826, 1994
15. Brasseur F, Marchand M, Vanwijck R, Hérin M, Lethé B, Chomez P, Boon T: Human gene MAGE-1, which codes for a tumor rejection antigen, is expressed by some breast tumors, Int J Cancer 52:839, 1992
16. Takahashi K, Schichijo S, Noguchi M, Hirohata M, Itoh K: Identification of MAGE-1 and MAGE-4 proteins in spermatogonia and primary spermatocytes of testis. Cancer Res 55:3478, 1995
17. Robbins PF, El-Gamil M, Li YF, Kawakami Y, Loftus D, Appella E, Rosenberg SA: A mutated β-catenin gene encodes a melanoma-specific antigen recognized by tumor infiltrating lymphocytes. J Exp Med 183:1185, 1996
18. Joly P, Charlotte F, Leibowitch M, Wechsler J, Haioun C, Escande JP, Reyes F, Revuz J, Bagot M: Cutaneous lymphomas other than mycosis fungoides. Immunophenotypic and follow-up study of 52 patients. J Clin Oncol 9:1994, 1991
19. Willemze R, Kerl H, Sterry W, Berti E, Cerroni L, Chimenti S, Diaz-Perez JL, Geerts ML, Goos M, Knobler R, Ralfkiaer E, Santucci M, Smith N, Wechsler J, van Vloten WA, Meijer CJLM: EORTC classification for primary cutaneous lymphomas. A proposal from the Cutaneous Lymphoma Study Group of the European Organization for Research and Treatment of Cancer. Blood 90:354, 1997
20. Bagot M, Wechsler J, Lescs MC, Revuz J, Farcet JP, Gaulard P: Intra-epidermal localization of the clone in cutaneous T-cell lymphoma. J Am Acad Dermatol 27:589, 1992
21. Michie SA, Abel EA, Hoppe RT, Picker LJ, Warnke RA, Wood GS: Expression of T-cell receptor antigens in mycosis fungoides and inflammatory skin lesions. J Invest Dermatol 93:116, 1989
22. Heald PW, yan S, Edelson RL, Tigelaar R, Picker LJ: Skin-selective lymphocyte homing mechanisms in the pathogenesis of leukemic cutaneous T-cell lymphoma. J Invest Dermatol 101:222, 1993
23. Friedmann D, Wechsler J, Delfau MH, Esteve E, Farcet JP, de Muret A, Parneix-Spake A, Vaillant L, Revuz J, Bagot M: Primary cutaneous pleomorphic small T-cell lymphoma: A review of 11 cases. Arch Dermatol 131:1009, 1995
24. + tumor-infiltrating lymphocytes expressing an activated. MHC-restricted cytotoxic T-lymphocyte phenotype. J Cutan Pathol 21:151, 1994
25. Berger CL, Wang N, Christensen I, Longley J, Heald P, Edelson RL: The immune response to class I-associated tumor-specific cutaneous T-cell lymphoma antigens. J Invest Dermatol 107:392, 1996
26. Tian Q, Streuli M, Saito H, Schlossman SF, Anderson P: A polyadenylate binding protein localized to granules of cytolytic lymphocytes induces DNA fragmentation in target cells. Cell 67:629, 1991
27. Bourge JF, Degos L, Bensussan A: Human T lymphocyte clones with killer or natural killer activity. J Immunol Meth 90:215, 1986
28. Boumsell L: T-cell antigens: section report, in Schlossman SF, Boumsell L, Gilks W, Harlan JM, Kishimoto T, Morimoto C, Ritz J, Shaw S, Silverstein R, Springer T, Tedder TF, Todd RF (eds): Leukocyte Typing V. Oxford, UK, Oxford University Press, 1995, p 241
29. Maïza H, Leca G, Mansur IG, Schiavon V, Boumsell L, Bensussan A: A novel 80-kDa cell surface structure identities human circulating lymphocytes with natural killer activity. J Exp Med 178: 1121, 1993
30. Puisieux I, Even J, Pannetier C, Jotereau F, Favrot M, Kourilsky P: Oligoclonality of tumor-infiltrating lymphocytes from human melanomas. J Immunol 153:2807, 1994
31. Genevée C, Diu A, Nierat J, Caignard A, Dietrich PY, Ferradini L, Roman-Roman S, Triebel F, Hercend T: An experimentally validated panel of subfamily-specific oligonucleotide primers (Vα1-w29/Vβ1-w24) for the study of human T cell receptor variable V gene segment usage by polymerase chain reaction. Eur J Immunol 22:1261, 1992
32. Hoppe RT, Medeiros LJ, Warnke RA, Wood GS: CD8-positive tumor-infiltrating lymphocytes influence the long-term survival of patients with mycosis fungoides. J Am Acad Dermatol 32:448, 1995
33. Lynch DH, Miller RE: Interleukin 7 promotes long-term in vitro growth of anti-tumor cytotoxic T lymphocytes with immunotherapeutic efficacity in vivo. J Exp Med 179:31, 1994
34. Dalloul A, Laroche L, Bagot M, Djavad Mossalayi M, Fourcade C, Thacker DJ, Hogge DE, Merle-Béral H, Debré P, Schmitt C: Interleukin-7 is a growth factor for Sézary lymphoma cells. J Clin Invest 90:1054, 1992
35. Foss FM, Koc Y, Stetler-Stevenson MA, Nguyen DT, O'Brien MC, Turner R, Sausville EA: Costimulation of cutaneous T-cell lymphoma cells by interleukin-7 and interleukin-2. Potential autocrine or paracrine effectors in the Sézary syndrome. J Clin Oncol 12:326, 1994
36. Heufler C, Topar G, Grasseger A, Stanzl U, Koch F, Romani N, Namen AE, Schuler G: Interleukin 7 is produced by murine and human keratinocytes. J Exp Med 178:1109, 1993
37. Rich BE, Campos-Torres J, Tepper RI, Moreadith RW, Leder P: Cutaneous lymphoproliferation and lymphomas in interleukin 7 transgenic mice. J Exp Med 177:305, 1993
38. Bagot M, Charue D, Boulland ML, Gaulard P, Revuz J, Schmitt C, Wechsler J: Interleukin-7 receptor expression in cutaneous T-cell lymphomas. Br J Dermatol 135:572, 1996
39. Dufour E, Carcelain G, Gaudin C, Flament C, Avril MF, Faure F: Diversity of the cytotoxic melanoma-specific immune response. Some CTL clones recognize autologous fresh tumor cells and not tumor cell lines. J Immunol 158:3787, 1997
40. + T cells with genuine class I restriction. Eur J Immunol 22:875, 1992
41. + thymocytes selected by MHC class I molecules. Science 263:1774, 1994
42. + class I-restricted T cells specific for HIV gp160 315-329. Cell Immunol 154:43, 1994
43. Matsubayashi Y, Zenita K, Morioka A, Iwashiro M, Masuda T, Uchino H, Fujita T, Kuribayashi K: Characterization of a CD4(L3T4)-positive cytotoxic T cell clone that is restricted by class I major histocompatibility complex antigen on FBL-3 tumor cell. Immunobiology 180:33, 1989
44. - T-cell clones established from autologous mixed lymphocyte-tumor-cell culture (MLTC). Int J Cancer 51:962, 1992
45. + cytotoxic T cell clone. Eur J Immunol 22:2461, 1992
46. Whang-Peng J, Bunn P, Knutsen T, Schechter GP, Gazdar AF, Matthews MJ, Minna JD: Cytogenetic abnormalities in patients with cutaneous T-cell lymphomas. Cancer Treat Rep 63:575, 1979
47. Padovan E, Giachino C, Cella M, Valitutti S, Acuto O, Lanzavecchia A: Normal T lymphocytes can express two different T cell receptor beta chains: implications for the mechanism of allelic exclusion. J Exp Med 181:1587, 1995
48. Zier K, Gansbacher B, Salvadori S: Preventing abnormalities in signal transduction of T cells in cancer: The promise of cytokine gene therapy, Immunol Today 17:39, 1996
49. Asadullah K, Döcke WD, Haeußler A, Sterry W, Volk HD: Progression of mycosis fungoides is associated with increasing cutaneous expression of interleukin-10 mRNA. J Invest Dermatol 107:833, 1996
50. Hahne M, Rimoldi D, Schröter M, Romero P, Schreier M, French LE, Schneider P, Bornand T, Fontana A, Lienard D, Cerottini JC, Tschopp J: Melanoma cell expression of Fas(Apo-1/CD95) ligand. Implications for tumor immune escape. Science 274:1363, 1996
51. Kwak LW, Campbell MJ, Czerwinski DK, Hart S, Miller RA, Levy R: Induction of immune responses in patients with B-cell lymphoma against the surface-immunoglobulin idiotype expressed by their tumors. N Engl J Med 327:1209, 1992